#Hierba life full

The Company also has announced details related to its transformation program, which will realign the Company and its employees to better support distributors and their customers, as well as invest in technology for the future.

#Hierba life full

Full year 2022 guidance assumes $50 million in share repurchases per quarter. Guidance for adjusted 2 diluted EPS is within the range of $4.25 – $4.75, and adjusted 2 EBITDA guidance is $785 million - $845 million. Given current inflationary pressures, the Company expects 2022 adjusted 2 diluted EPS and adjusted 2 EBITDA to be impacted due to higher than usual cost increases within its supply chain. Looking to the future, the Company has initiated full year 2022 guidance, including net sales in the range of flat to 6% growth. The Company announced additional investments in the Indian market with the opening of a 155,000 square foot center of excellence that will house a new global business services center, quality laboratory, distributor innovation space, as well as a research and development facility.

On a two-year stack basis, the Company saw growth of 8% compared to the fourth quarter 2019.ĭuring the quarter, the Indian business continued its growth trajectory with a year-over-year increase in net sales of 33%. Additionally, the Company announced record sales leader retention results for the last 12-month requalification period ending in January of 2022 of 68.9%.įor the fourth quarter 2021, net sales declined 7% compared to the fourth quarter 2020 as the year-over-year trend was impacted by a challenging comparison period. Over the course of the year the Company added 2.9 million new distributors and preferred members. In 2021, the number of distributors continued to grow as more individuals are seeking entrepreneurial and flexible business opportunities, while fulfilling the increasing global demand for health & wellness products. “Global trends continue to drive demand for our science-backed nutrition products, resulting in another record year for Herbalife Nutrition,” said Chairman and CEO John Agwunobi. Additionally, the Company completed approximately $1 billion in share repurchases during the year. The Company also set annual records for reported diluted EPS, adjusted 1 diluted EPS, reported net income and adjusted 1 EBITDA. Herbalife Nutrition reported net sales of $5.8 billion for the full year 2021, an increase of 5% compared to the prior year and an annual record for the Company. See the “Outlook” discussion below and the related footnotes and Schedule A – “Reconciliation of Non-GAAP Financial Measures” for additional information regarding adjusted diluted EPS and adjusted EBITDA guidance. See Schedule A – “Reconciliation of Non-GAAP Financial Measures” for a detailed reconciliation of these measures to the most directly comparable GAAP measure, and a discussion of why we believe these non-GAAP measures are useful.Ģ Adjusted diluted EPS and adjusted EBITDA are non-GAAP measures.

Guidance assumes $50 million in share repurchases per quarter.ġ Adjusted diluted EPS and adjusted EBITDA are non-GAAP measures. Initiating FY 2022 net sales guidance range of 0% - 6% growth, adjusted 2 diluted EPS guidance range of $4.25 – $4.75, and adjusted 2 EBITDA guidance of $785 million - $845 million. The Company’s three largest regions: Asia Pacific, North America and EMEA, each set annual net sales records.įull year 2021 reported diluted EPS of $4.13 and adjusted 1diluted EPS of $4.79, increased by approximately 49% and 29%, respectively, compared to the full year 2020 reported and adjusted 1 diluted EPS of $2.77 and $3.71, respectively.įull year 2021 reported net income of $447.2 million and adjusted 1 EBITDA of $873.5 million, both annual records for the Company.ĭuring the full year, the Company repurchased approximately 20.4 million shares for a total purchase price of $983 million.įourth quarter 2021 net sales of $1.3 billion decreased 6.6% compared to the fourth quarter 2020.įourth quarter 2021 reported diluted EPS of $0.37 and adjusted 1 diluted EPS of $0.57, compared to $0.59 and $0.71, respectively, for the fourth quarter 2020.įourth quarter 2021 reported net income of $38.2 million and adjusted 1 EBITDA of $131.6 million. “Global trends continue to drive demand for our science-backed nutrition products, resulting in another record year for Herbalife Nutrition,” said John Agwunobi, Chairman and CEO of Herbalife Nutrition.įull year 2021 net sales of $5.8 billion increased 4.7% compared to full year 2020, representing the largest annual net sales result in Company history.

(NYSE: HLF) today reported financial results for the fourth quarter and full year ended December 31, 2021. LOS ANGELES-( BUSINESS WIRE)-Herbalife Nutrition Ltd.